• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASHP therapeutic guidelines on angiotensin-converting-enzyme inhibitors in patients with left ventricular dysfunction. This official ASHP practice standard was developed through the ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 16, 1996.

出版信息

Am J Health Syst Pharm. 1997 Feb 1;54(3):299-313. doi: 10.1093/ajhp/54.3.299.

DOI:10.1093/ajhp/54.3.299
PMID:9028424
Abstract
摘要

相似文献

1
ASHP therapeutic guidelines on angiotensin-converting-enzyme inhibitors in patients with left ventricular dysfunction. This official ASHP practice standard was developed through the ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 16, 1996.美国卫生系统药师协会（ASHP）关于左心室功能不全患者使用血管紧张素转换酶抑制剂的治疗指南。本ASHP官方实践标准由ASHP治疗委员会制定，并于1996年11月16日经ASHP董事会批准。
Am J Health Syst Pharm. 1997 Feb 1;54(3):299-313. doi: 10.1093/ajhp/54.3.299.
2
Promoting use of angiotensin-converting-enzyme inhibitors.
Am J Health Syst Pharm. 1997 Feb 1;54(3):264. doi: 10.1093/ajhp/54.3.264.
3
Letter regarding article by Masoudi et al, "national patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction".
Circulation. 2005 May 3;111(17):e276-7; author reply e276-7. doi: 10.1161/01.CIR.0000163540.84871.16.
4
Reasons for underuse of angiotensin-converting enzyme inhibitors in patients with heart failure and left ventricular dysfunction.心力衰竭和左心室功能障碍患者血管紧张素转换酶抑制剂使用不足的原因。
Am J Cardiol. 1997 Apr 15;79(8):1118-20. doi: 10.1016/s0002-9149(97)00060-x.
5
ASHP guidelines on the pharmacist's role in home care. Developed through the ASHP Council on Professional Affairs with the assistance of the Executive Committee and Professional Practice Committee of the ASHP Section of Home Care Practitioners and approved by the ASHP Board of Directors on April 27, 2000.美国卫生系统药师协会（ASHP）关于药师在家庭护理中作用的指南。由ASHP专业事务委员会在家庭护理从业者ASHP分会执行委员会和专业实践委员会的协助下制定，并于2000年4月27日经ASHP董事会批准。
Am J Health Syst Pharm. 2000 Jul 1;57(13):1252-7. doi: 10.1093/ajhp/57.13.1252.
6
Angiotensin converting enzyme inhibitors for heart failure with reduced ejection fraction or left ventricular dysfunction: A complementary network meta-analyses.
Int J Cardiol. 2016 Jul 1;214:10-2. doi: 10.1016/j.ijcard.2016.03.173. Epub 2016 Mar 24.
7
[ACE inhibitors continue to be first choice in the treatment of heart failure patients].血管紧张素转换酶抑制剂仍是治疗心力衰竭患者的首选药物。
Ugeskr Laeger. 2013 May 27;175(22):1566-8.
8
Should angiotensin receptor blockers be added to angiotensin-converting enzyme inhibitors in the treatment of heart failure?在心力衰竭治疗中，是否应将血管紧张素受体阻滞剂添加到血管紧张素转换酶抑制剂中？
Rev Cardiovasc Med. 2005 Fall;6(4):206-13.
9
Effect of angiotensin-converting enzyme inhibition on functional class in patients with left ventricular systolic dysfunction--a meta-analysis.血管紧张素转换酶抑制对左心室收缩功能不全患者心功能分级的影响——一项荟萃分析。
Eur J Heart Fail. 2006 Jan;8(1):90-6. doi: 10.1016/j.ejheart.2005.03.006. Epub 2005 Jul 27.
10
Treating diastolic heart failure: the role of ACE inhibitors.
Rev Port Cardiol. 1999 Sep;18 Suppl 5:V101-6.

引用本文的文献

1
Underutilisation of ACE inhibitors in patients with congestive heart failure.充血性心力衰竭患者中血管紧张素转换酶抑制剂的使用不足。
Drugs. 2001;61(14):2021-33. doi: 10.2165/00003495-200161140-00002.
2
Fosinopril. A review of its pharmacology and clinical efficacy in the management of heart failure.福辛普利。其治疗心力衰竭的药理学及临床疗效综述。
Drugs. 1997 Jul;54(1):103-16. doi: 10.2165/00003495-199754010-00012.